JCCC Research Seminar featuring Dr. David Dawson
Defining the metabolic landscape of Wnt-dependent pancreatic cancer
- Date: April 25, 2019 12:00 PM - 1:00 PM
- Location: 53-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095
David Dawson, M.D., Ph.D.
Associate Professor, Department of Pathology and Laboratory Medicine
Associate Director, UCLA-Caltech MSTP
Dr. David Dawson is interested in molecular changes responsible for the development and progression of pancreatic adenocarcinoma. His primary research is focused on the regulation and function of Wnt signaling in pancreatic cancer progression with the long term goals of developing clinically useful Wnt-based biomarkers and therapeutic strategies. He is also seeking to understand the spectrum of epigenetic events causally linked to pancreatic tumorigenesis, as well as the factors responsible for dictating changes in DNA methylation and post-translational histone modifications during pancreatic tumor initiation and progression.
Light lunch served
Sponsored by the UCLA Jonsson Comprehensive Cancer Center Signal Transduction and Therapeutics Program